Danaher CEO Julie Sawyer Montgomery says the company's partnership with AI giant NVIDIA will help “researchers move faster to advance discoveries”…

INTERPOL Secretary General Valdecy Urquiza says the agreement with WHO is crucial to security efforts as “crime and health are increasingly interconnected”…

IBM’s Kaitlyn Roche and MVP Health Care’s Samantha Demick shared insights on automating healthcare vendor compliance and managing risk in a webinar…

The Rush-Endeavor merger will bring together 12 hospitals and more than 400 care sites, aimed at strengthening research and healthcare access…

More News

Featured

This week's top stories include J&J's menopause-eye health link, the UK's AI healthcare regulations, GE's HealthCare's CT technology and Bayer's Ohio site…

Read more

WHO’s Director of Nutrition and Food Safety, Dr Luz María De Regill, says childhood obesity care should focus on "support" not "medicine or surgery"…

Read more
Featured

Spencer Stiles, who will assume the CEO position after serving as COO at Stryker since January 2026, describes taking the role as a “tremendous privilege”…

Read more
Featured

CEO Mike Mahoney names Joe Fitzgerald EVP & COO at Boston Scientific as the medtech giant restructures into three clinical segments…

Read more

CEO Brian Tyler will bring McKesson’s “experience and expertise” to support Option Care Health, following a US$5.8bn joint acquisition…

Read more
Featured

Danaher CEO Julie Sawyer Montgomery described the planned AI lab as “an important milestone” towards expediting “the journey from discovery to impact”…

Read more
Featured

CEO Pascal Soriot says AstraZeneca’s R&D centre in Massachusetts will help the company to "discover the next generation of scientific breakthroughs"…

Read more

Deputy Chair of the National Commission into the Regulation of AI in Healthcare, Henrietta Hughes, welcomed the decision to accept all 44 recommendations…

Read more
Featured

GE HealthCare’s Chad Rowland discusses Photonova Spectra, Deep Silicon and the future of photon-counting CT following its CE Mark approval in August 2026…

Read more
Featured

Bayer’s Global COO Sebastian Guth says the facility will help the German company bring its “next generation of medicines to patients around the world”…

Read more